Antimicrobial resistance for Neisseria gonorrhoeae in the united states, 1988 to 2003:: The spread of fluoroquinolone resistance

被引:36
|
作者
Wang, Susan A.
Harvey, Alesia B.
Conner, Susan M.
Zaidi, Akbar A.
Knapp, Joan S.
Whittington, William L. H.
del Rio, Carlos
Judson, Franklyn N.
Holmes, King K.
机构
[1] Emory Univ, Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Sch Med, Atlanta, GA 30333 USA
[2] Emory Ctr AIDS Res, Atlanta, GA USA
[3] Medtronic, Memphis, TN USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Univ Colorado, Sch Med, Denver, CO USA
关键词
D O I
10.7326/0003-4819-147-2-200707170-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Over the past 60 years, Neisseria gonorrhoeae has acquired clinically significant resistance to sulfonamides, tetracyclines, penicillins, and ciprofloxacin. Objective: To determine U.S. trends in the prevalence of antimicrobial resistance of N. gonorrhoeae from 1988 to 2003. Design: 16-year, multisite, sentinel surveillance for gonococcal isolate susceptibility through the Gonococcal Isolate Surveillance Project (GISP). Setting: Sexually transmitted disease clinics in 37 cities. Patients: Male patients with a total of 82 064 episodes of urethral gonorrhea. Measurements: Primary outcome measures included percentage of gonococcal isolates resistant to antimicrobials used to treat gonorrhea, percentage of patients treated with specific antimicrobials for gonorrhea, and trends of these measures over time. Results: The median age of patients was 26 years, and 74.1% of patients were African American. The proportion of men treated with penicillins for gonorrhea declined from 39.5% in 1988 to 0% in 1994, while the proportion of those receiving fluoroquinolone treatment increased from 0% in 1988 to 42.0% in 2003. Penicillin resistance peaked at 19.6% in 1991, then declined to 6.5% in 2003. Tetracycline resistance peaked at 25.8% in 1997 and declined to 14.4% in 2003. The first fluoroquinolone-resistant isolate was found in 1991. Nationally, 0.4% of isolates were fluoroquinolone-resistant in 1999 and were identified in 39% of GISP cities. By 2003, 4.1 % of isolates were fluoroquinolone-resistant and were identified in 70% of GISP cities. Isolates with decreased susceptibility to ceftriaxone, cefixime, azithromycin, and spectinomycin remained rare. In 2001, 3 multidrug-resistant isolates with decreased susceptibility to cefixime were identified. Limitation: Sentinel surveillance may not fully reflect trends for all patients with gonorrhea in the United States. Conclusions: Prevalence of penicillin resistance has declined in the years since gonorrhea treatment with penicillin was discontinued. Fluoroquinolone-resistant N. gonorrhoeae infections continue to increase at a time when fluoroquinolone use has increased. Ongoing nationwide and local antimicrobial susceptibility monitoring is crucial to ensure appropriate treatment of gonorrhea.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
  • [1] Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones
    Fox, KK
    Knapp, JS
    Holmes, KK
    Hook, EW
    Judson, FN
    Thompson, SE
    Washington, JA
    Whittington, WL
    JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06): : 1396 - 1403
  • [2] ESTIMATING THE POTENTIAL ECONOMIC IMPACT OF ANTIMICROBIAL RESISTANCE IN NEISSERIA GONORRHOEAE IN THE UNITED STATES
    Chesson, H.
    Owusu-Edusei, K., Jr.
    Kirkcaldy, R. D.
    Gift, T. L.
    Weinstock, H. S.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A365 - A365
  • [3] TRENDS IN RESISTANCE OF NEISSERIA-GONORRHOEAE TO ANTIMICROBIAL AGENTS IN THE UNITED-STATES
    WHITTINGTON, WL
    KNAPP, JS
    SEXUALLY TRANSMITTED DISEASES, 1988, 15 (04) : 202 - 210
  • [4] Antimicrobial resistance in Neisseria gonorrhoeae
    Lind, I
    CLINICAL INFECTIOUS DISEASES, 1997, 24 : S93 - S97
  • [5] Molecular mechanisms of fluoroquinolone resistance to Neisseria gonorrhoeae
    Zou, MX
    Xia, ZD
    Tang, Y
    Liu, WE
    Chen, SZ
    Liu, HL
    PROCEEDINGS OF THE 2003 SYMPOSIUM OF CHINA POSTDOCTORS AND ACADEMICIANS ON LIFE SCIENCE, 2003, : 375 - 379
  • [6] Antimicrobial resistance of Neisseria gonorrhoeae in Liberia
    Guyot, A
    Jarrett, B
    Sanvee, L
    Dore, D
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (06) : 670 - 674
  • [7] ANTIMICROBIAL RESISTANCE IN NEISSERIA-GONORRHOEAE
    RICE, RJ
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1992, 59 (01) : 97 - 98
  • [8] Genotypic determinants of fluoroquinolone and macrolide resistance in Neisseria gonorrhoeae
    Hall, Catherine L.
    Harrison, Mark A.
    Pond, Marcus J.
    Chow, Christine
    Harding-Esch, Emma M.
    Sadiq, S. Tariq
    SEXUAL HEALTH, 2019, 16 (05) : 479 - 487
  • [9] Fluoroquinolone Resistance in Neisseria gonorrhoeae: Fitness Cost or Benefit?
    Dillon, Jo-Anne R.
    Parti, Rajinder P.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (12): : 1775 - 1777
  • [10] Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu Province, China, with a focus on fluoroquinolone resistance
    Wang, Bei
    Xu, Jin-shui
    Wang, Chang-xian
    Mi, Zu-huang
    Pu, Yue-pu
    Hui, Mamie
    Ling, Thomas K. W.
    Chan, Chiu-Yeung
    JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (09) : 1251 - 1255